NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

cancer weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of cancer weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Bone Cancer



Research on bone cancer discussed by R.N. Wahane and co-researchers



December 18th, 2007

"Objective To study the role of fine needle aspiration cytology (FNAC) in the diagnosis of bone tumors and its impact on therapeutic decisions. Study Design A group of 122 cases of hone tumor were evaluated by FNAC," researchers in Nagpur, India report.

"Detailed diagnoses were compared with the available histology. Results Diagnostic accuracy of FNAC was 90.5% in this study. FNAC could differentiate between various round cell tumors such as Ewing's sarcoma and myeloma, among various giant cell-rich lesions of hone and between the benign and malignant chondroid hone tumors. Some uncommon variants were also correctly diagnosed. In metastatic bone tumors, the source of...


Source: cancer weekly (2007-12-18)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login